Multiplexing seven miRNA-Based shRNAs to suppress HIV replication

Molecular Therapy

Volumn 23, Issue 2, 2015, Pages 310-320

  Choi, Jang Gi ^a   Bharaj, Preeti ^a   Abraham, Sojan ^a   Ma, Hongming ^a   Yi, Guohua ^a   Ye, Chunting ^a   Dang, Ying ^a   Manjunath, N ^a   Wu, Haoquan ^a   Shankar, Premlata ^a  

^a Paul L Foster School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 SHORT HAIRPIN RNA; CHEMOKINE RECEPTOR CCR5; GAG PROTEIN; LENTIVIRUS VECTOR; MICRORNA; POL 1 PROTEIN; POL 2 PROTEIN; POL PROTEIN; SHORT HAIRPIN RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; RNA PROCESSING; SEQUENCE ANALYSIS; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; CELL LINE; DISEASE MODEL; GENE EXPRESSION; GENE ORDER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; RNA INTERFERENCE; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

ANIMALS; CD4 LYMPHOCYTE COUNT; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE ORDER; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; RECEPTORS, CCR5; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTE SUBSETS; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 84922224353     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.205     Document Type: Article

References (45)

1. Davidson BL and McCray PB Jr. (2011). Current prospects for RNA interference-based therapies. Nat Rev Genet 12: 329-340
2. Lee SK, Dykxhoorn DM, Kumar P, Ranjbar S, Song E, Maliszewski LE., et al. (2005). Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106: 818-826
3. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A., et al. (2002). Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20: 500-505
4. DiGiusto DL, Krishnan A, Li L, Li H, Li S, Rao A., et al. (2010). RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2: 36ra43
5. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR., et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541
6. McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I., et al. (2008). Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 105: 5868-5873
7. Boudreau RL, Monteys AM and Davidson BL. (2008). Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. RNA 14: 1834-1844
8. Grimm D, Wang L, Lee JS, Schürmann N, Gu, S, Börner K., et al. (2010). Argonaute proteins are key determinants of RNAi efficacy toxicity and persistence in the adult mouse liver. J Clin Invest 120: 3106-3119
9. Boudreau RL, Martins I and Davidson BL. (2009). Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther 17: 169-175
10. Lo, HL, Chang T, Yam P, Marcovecchio PM, Li S, Zaia JA., et al. (2007). Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters. Gene Ther 14: 1503-1512
11. Boden D, Pusch O, Lee F, Tucker L and Ramratnam B. (2003). Human immunodeficiency virus type 1 escape from RNA interference. J Virol 77: 11531-11535
12. Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R., et al. (2004). Human immunodeficiency virus type 1 escapes from RNA interferencemediated inhibition. J Virol 78: 2601-2605
13. ter Brake O, Konstantinova P, Ceylan M and Berkhout B. (2006). Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 14: 883-892
14. ter Brake O, T'Hooft K, Liu YP, Centlivre M, von Eije KJ and Berkhout B. (2008). Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 16: 557-564
15. Liu YP, Haasnoot J, ter Brake O, Berkhout B and Konstantinova P. (2008). Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res 36: 2811-2824
16. Aagaard LA, Zhang J, von Eije KJ, Li H, Saetrom P, Amarzguioui M., et al. (2008). Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Gene Ther 15: 1536-1549
17. Chung J, Zhang J, Li H, Ouellet DL, DiGiusto DL and Rossi JJ. (2012). Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy. Hum Gene Ther 23: 1200-1208
18. McIntyre GJ, Groneman JL, Yu, YH, Tran A and Applegate TL. (2011). Multiple shRNA combinations for near-complete coverage of all HIV-1 strains. AIDS Res Ther 8: 1
19. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH., et al. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060
20. Cai X, Hagedorn CH and Cullen BR. (2004). Human microRNAs are processed from capped polyadenylated transcripts that can also function as mRNAs. RNA 10: 1957-1966
21. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J., et al. (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419
22. Han J, Lee Y, Yeom KH, Kim YK, Jin H and Kim VN. (2004). The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18: 3016-3027
23. Yi, R, Qin Y, Macara IG and Cullen BR. (2003). Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011-3016
24. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K., et al. (2005). TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436: 740-744
25. Chang K, Elledge SJ and Hannon GJ. (2006). Lessons from Nature: microRNA-based shRNA libraries. Nat Methods 3: 707-714
26. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK., et al. (2006). Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125: 887-901
27. Ma, H, Wu, Y, Choi JG and Wu, H. (2013). Lower and upper stem-single-stranded RNA junctions together determine the Drosha cleavage site. Proc Natl Acad Sci USA 110: 20687-20692
28. Agosto LM, Yu, JJ, Liszewski MK, Baytop C, Korokhov N, Humeau LM., et al. (2009). The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope. J Virol 83: 8153-8162
29. Yu, D, Wang W, Yoder A, Spear M and Wu, Y. (2009). The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells. PLoS Pathog 5: e1000633
30. Kumar P, Ban HS, Kim SS, Wu, H, Pearson T, Greiner DL., et al. (2008). T cellspecific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134: 577-586
31. Surabhi RM and Gaynor RB. (2002). RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication. J Virol 76: 12963-12973
32. Ma, H, Wu, Y, Dang Y, Choi JG, Zhang J and Wu, H. (2014). Pol III Promoters to Express Small RNAs: Delineation of Transcription Initiation. Mol Ther Nucleic Acids 3: e161
33. Tan X, Lu, ZJ, Gao G, Xu, Q, Hu L, Fellmann C., et al. (2012). Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy. Proc Natl Acad Sci USA 109: 869-874
34. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O., et al. (2008). Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816
35. Carroll D. (2011). Genome engineering with zinc-finger nucleases. Genetics 188: 773-782
36. Bogdanove AJ and Voytas DF. (2011). TAL effectors: customizable proteins for DNA targeting. Science 333: 1843-1846
37. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE., et al. (2013). RNA-guided human genome engineering via Cas9. Science 339: 823-826
38. Knoepfel SA, Centlivre M, Liu YP, Boutimah F and Berkhout B. (2012). Selection of RNAi-based inhibitors for anti-HIV gene therapy. World J Virol 1: 79-90
39. Reed JR, Vukmanovic-Stejic M, Fletcher JM, Soares MV, Cook JE, Orteu CH., et al. (2004). Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med 199: 1433-1443
40. Perez LG, Costa MR, Todd CA, Haynes BF and Montefiori DC. (2009). Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41. J Virol 83: 7397-7410
41. Wu, H, Ma H, Ye, C, Ramirez D, Chen S, Montoya J., et al. (2011). Improved siRNA/shRNA functionality by mismatched duplex. PLoS ONE 6: e28580
42. Singh A, Palanichamy JK, Ramalingam P, Kassab MA, Bhagat M, Andrabi R., et al. (2014). Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA. J Antimicrob Chemother 69: 404-415
43. Green VA, Arbuthnot P and Weinberg MS. (2012). Impact of sustained RNAimediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cells. Virol J 9: 272
44. Schopman NC, ter Brake O and Berkhout B. (2010). Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Retrovirology 7: 52
45. Sugiyama R, Hayafune M, Habu Y, Yamamoto N and Takaku H. (2011). HIV-1 RTdependent DNAzyme expression inhibits HIV-1 replication without the emergence of escape viruses. Nucleic Acids Res 39: 589-598